Former Life-er heads for Freedom
This article was originally published in Clinica
Executive Summary
A former executive at Life Technologies has joined Freedom Meditech, a San Diego, California company developing an eye-based diagnostic system for monitoring diabetes, as CEO. John Gerace led the Applied Sciences division of Life Technologies and also served as vice-president and general manager of the company’s PCR Systems business unit. At Freedom Meditech, he will oversee all company operations, build the management team and help raise funds to expand commercialization of ClearPath DS-120, the company’s US FDA-cleared tool for measuring autofluorescence in the eye. Studies have suggested that elevated lens autofluorescence may be an early indicator of the presence of diabetes.